Smith & Nephew will unveil its ALLEVYN™ COMPLETE CARE Foam Dressing and RENASYS™ EDGE Negative‑Pressure Wound Therapy System at the European Wound Management Association (EWMA) Conference in Bremen, Germany, from May 6‑8, 2026. The company’s announcement introduces a five‑layer dressing that incorporates ExuLOCK™ technology to lock in exudate and bacteria, an ExuMASK™ change indicator for extended wear, and ShearDEFENSE™ unbonded layers that protect against pressure injuries. The RENASYS™ EDGE system is a lightweight, portable NPWT device that offers simplified operation, reduced maintenance, and a reported 88% therapy‑session compliance in internal studies.
The ALLEVYN™ COMPLETE CARE Dressing builds on Smith & Nephew’s proprietary technologies to deliver superior exudate management and bacterial containment, with a 99% bacterial barrier and a higher absorbency profile than competing foam dressings. The dressing’s ShearDEFENSE™ layer mitigates shear forces that contribute to pressure injuries, positioning it as a dual‑purpose solution for wound care and pressure injury prevention. The RENASYS™ EDGE system’s 2‑lb weight, 24‑hour battery life, and step‑by‑step guidance make it suitable for home‑based care, addressing a growing market segment that demands portability and ease of use.
Smith & Nephew’s Advanced Wound Management segment has been a key growth driver, delivering underlying revenue growth above 5% in 2025 and strong performance in the fourth quarter. By launching these products at EWMA, the company reinforces its leadership in chronic wound care and signals confidence in the expanding demand for advanced dressings and portable NPWT solutions. Rohit Kashyap, President of Advanced Wound Management, emphasized that the new dressing “reflects our continued commitment to wound care innovation, delivering meaningful benefit where it matters most.”
The wound‑care market remains highly competitive, with several players offering advanced dressings and NPWT systems. Smith & Nephew’s focus on proprietary technologies such as ExuLOCK™, ExuMASK™, and ShearDEFENSE™ differentiates its offerings, while the RENASYS™ EDGE’s patient‑centric design addresses a critical need for home‑based therapy. The launch is expected to strengthen the company’s market position and support future revenue growth in the Advanced Wound Management segment.
The introduction of the ALLEVYN™ COMPLETE CARE Dressing and RENASYS™ EDGE System at EWMA 2026 underscores Smith & Nephew’s strategy to expand its Advanced Wound Management portfolio and capitalize on the growing demand for high‑performance wound‑care solutions. The products’ advanced technologies and patient‑centric design are poised to enhance clinical outcomes and reinforce the company’s leadership in chronic wound care.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.